The pharmaceutical major reported revenue of Rs 7,404 crore for the September quarter, while EBITDA margin contracted to 18.7 per cent from 25 per cent a year ago
The ruling, delivered on September 28 by Justice Harisankar V. Menon, is being read as one of the clearest High Court elaborations yet of Section 100 of the Patents Act, 1970
The medicines include treatments for blood pressure, diabetes, cholesterol, infections and allergies, along with changes affecting a rabies injection and a patented vaccine
The Union Health Ministry has banned the manufacture, sale and distribution of all oral nimesulide formulations above 100 mg, citing serious risks to human health
Experts warn a proposed 'data exclusivity' rule in India could severely delay affordable generic medicines, create drug monopolies, and threaten its role as the 'pharmacy of the world'
Indian officials found 112 drug samples 'not of standard quality' amidst a global WHO warning regarding contaminated cough syrups that led to 24 child deaths
The Regional Cancer Centre (RCC) in Kerala's Thiruvananthapuram has since blacklisted Globela Pharma, the pharmaceutical firm responsible for the packaging error
This comes after a Special Investigation Team (SIT) formed by the Madhya Pradesh government arrested the company's owner, G. Ranganathan
The Tamil Nadu government found that the cough syrup Coldrif that killed around 11 children in Madhya Pradesh contained excessive amounts of diethylene glycol (DEG) a solvent used in paint, anti-freeze and brake fluids. It is not the first time DEG in cough syrups led to the death of children in the country
India is one of the largest consumers of paracetamol in the world and experts note that the Trump-Kennedy campaign against the drug mirrors the anti-vaccine rhetoric that has hurt immunisation drives worldwide
The Trump administration plans to announce a link between Tylenol (also known as paracetamol) use during pregnancy and an increased risk of autism in children. However, the announcement faces strong opposition from medical organisations and Tylenol's manufacturer, who say that there is no credible evidence to support the link.
Experts urge widespread awareness, routine screening, and early intervention as critical steps to prevent life-threatening ruptures and manage this overlooked cardiovascular condition.